GSA Capital Partners LLP bought a new position in Walgreens Boots Alliance Inc (NASDAQ:WBA) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 23,740 shares of the pharmacy operator’s stock, valued at approximately $1,298,000.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Nelson Roberts Investment Advisors LLC acquired a new position in shares of Walgreens Boots Alliance in the 1st quarter worth $25,000. Meridian Wealth Management LLC acquired a new stake in shares of Walgreens Boots Alliance in the first quarter worth $25,000. Weaver Consulting Group acquired a new stake in shares of Walgreens Boots Alliance in the first quarter worth $27,000. Sageworth Trust Co acquired a new stake in shares of Walgreens Boots Alliance in the second quarter worth $27,000. Finally, Trustcore Financial Services LLC acquired a new stake in shares of Walgreens Boots Alliance in the first quarter worth $31,000. Institutional investors and hedge funds own 62.03% of the company’s stock.
Several analysts have recently commented on WBA shares. Morgan Stanley decreased their target price on Walgreens Boots Alliance from $61.00 to $58.00 and set an “equal weight” rating for the company in a research report on Friday. Bank of America decreased their target price on Walgreens Boots Alliance from $53.00 to $51.00 and set an “underperform” rating for the company in a research report on Monday, June 3rd. Zacks Investment Research cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating and set a $53.00 target price for the company. in a research report on Monday, June 10th. BidaskClub cut Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Monday, June 24th. Finally, ValuEngine raised Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Friday, June 28th. Six research analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $63.65.
WBA traded down $1.63 during trading on Friday, reaching $49.32. 4,700,031 shares of the stock traded hands, compared to its average volume of 4,649,112. The stock has a market cap of $46.02 billion, a price-to-earnings ratio of 8.19, a price-to-earnings-growth ratio of 1.27 and a beta of 0.81. Walgreens Boots Alliance Inc has a fifty-two week low of $49.12 and a fifty-two week high of $86.31. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.76 and a quick ratio of 0.37. The stock’s 50-day simple moving average is $53.61 and its two-hundred day simple moving average is $57.04.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $1.47 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.42 by $0.05. The firm had revenue of $34.59 billion during the quarter, compared to analysts’ expectations of $34.52 billion. Walgreens Boots Alliance had a return on equity of 22.08% and a net margin of 3.53%. The business’s revenue for the quarter was up .7% on a year-over-year basis. During the same quarter last year, the firm earned $1.53 earnings per share. Research analysts anticipate that Walgreens Boots Alliance Inc will post 5.99 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 12th. Investors of record on Tuesday, August 20th will be given a dividend of $0.458 per share. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. The ex-dividend date is Monday, August 19th. This represents a $1.83 dividend on an annualized basis and a yield of 3.71%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 30.40%.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Read More: Death Cross
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.